Featured Research

from universities, journals, and other organizations

European Disparities In Access To Cancer Drugs

Date:
September 15, 2008
Source:
European Society for Medical Oncology
Summary:
New research has highlighted stark disparities in access to the latest cancer drugs across European Union nations, according to new data.

New research has highlighted stark disparities in access to the latest cancer drugs across European Union nations, according to data presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

While countries like France, Spain, Austria and Switzerland have tended to introduce the new drugs quickly, researchers say, others such as the UK and more recent EU entrants bring them in more slowly.

Dr Nils Wilking from the Karolinska Institute in Sweden gathered data on the sales of newer drugs per inhabitant of each country provided by pharmaceutical industry consultants IMS Health. His group's focus was on the uptake of newer 'targeted' drugs over the past 10 years in 27 countries.

Overall, they found substantial variation between countries, both in terms of speed and uptake of newer cancer drugs, and the level of usage of the drugs.

"Of the major western EU countries, the UK tends to come out both low and slow with a few exceptions," Dr Wilking said. "Overall, Austria, Switzerland and France bring the new drugs out more quickly. France also has an especially high general uptake of most new drugs. Spain is somewhat lower and slower but was a 'leader' in the early part of the 2000s."

The cost of the newer drugs is probably the major barrier to access, Dr. Wilking said. "To some extent it could also relate to the introduction of more 'targeted' drugs that tend to be more complex to understand and, in some cases, have smaller studies to support their approval."

The impact of this disparity on the health of Europe's cancer patients is hard to say with certainty, Dr Wilking said. "It is a complicated area as the epidemiological data lags so much behind. We need much better epidemiological data in order to evaluate the link between access to cancer drugs and outcome."

Access to drugs is not the only factor involved in improving cancer outcomes, he added. "Patients need to have full access to the most innovative technologies in prevention, screening, surgery, radiotherapy and drugs."


Story Source:

The above story is based on materials provided by European Society for Medical Oncology. Note: Materials may be edited for content and length.


Cite This Page:

European Society for Medical Oncology. "European Disparities In Access To Cancer Drugs." ScienceDaily. ScienceDaily, 15 September 2008. <www.sciencedaily.com/releases/2008/09/080915121233.htm>.
European Society for Medical Oncology. (2008, September 15). European Disparities In Access To Cancer Drugs. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/2008/09/080915121233.htm
European Society for Medical Oncology. "European Disparities In Access To Cancer Drugs." ScienceDaily. www.sciencedaily.com/releases/2008/09/080915121233.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins